These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16048476)
1. Expression of scavenger receptor CD36 in chronic renal failure patients. Chmielewski M; Bryl E; Marzec L; Aleksandrowicz E; Witkowski JM; Rutkowski B Artif Organs; 2005 Aug; 29(8):608-14. PubMed ID: 16048476 [TBL] [Abstract][Full Text] [Related]
2. Mechanism linking atherosclerosis and type 2 diabetes: increased expression of scavenger receptor CD36 in monocytes. Zhang HM; Zhang XL; Zhou X; Li D; Gu JG; Wu JJ Chin Med J (Engl); 2005 Oct; 118(20):1717-22. PubMed ID: 16313757 [TBL] [Abstract][Full Text] [Related]
3. Aberrant activation of the TNF-alpha system and production of Fas and scavenger receptors on monocytes in patients with end-stage renal disease. Wu CC; Chen JS; Lin SH; Chu P; Lin YF; Lin SM; Liao TN Artif Organs; 2005 Sep; 29(9):701-7. PubMed ID: 16143011 [TBL] [Abstract][Full Text] [Related]
4. IGG and complement receptor expression on peripheral white blood cells in uraemic children. Bouts AH; Krediet RT; Davin JC; Monnens LA; Nauta J; Schröder CH; van de Winkel JG; Out TA Nephrol Dial Transplant; 2004 Sep; 19(9):2296-301. PubMed ID: 15266033 [TBL] [Abstract][Full Text] [Related]
5. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106 [TBL] [Abstract][Full Text] [Related]
6. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Kuroki Y; Tsuchida K; Go I; Aoyama M; Naganuma T; Takemoto Y; Nakatani T Int J Mol Med; 2007 May; 19(5):783-90. PubMed ID: 17390084 [TBL] [Abstract][Full Text] [Related]
7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752 [TBL] [Abstract][Full Text] [Related]
8. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity. Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996 [TBL] [Abstract][Full Text] [Related]
10. CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease. Teupser D; Mueller MA; Koglin J; Wilfert W; Ernst J; von Scheidt W; Steinbeck G; Seidel D; Thiery J Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):552-6. PubMed ID: 18067591 [TBL] [Abstract][Full Text] [Related]
11. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. Lewis SL; Van Epps DE; Chenoweth DE Clin Nephrol; 1986 Jul; 26(1):37-44. PubMed ID: 3488153 [TBL] [Abstract][Full Text] [Related]
12. Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors. Katayama I; Hotokezaka Y; Matsuyama T; Sumi T; Nakamura T Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):835-46. PubMed ID: 18262097 [TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Agrawal S; Febbraio M; Podrez E; Cathcart MK; Stark GR; Chisolm GM Circulation; 2007 Jun; 115(23):2939-47. PubMed ID: 17533179 [TBL] [Abstract][Full Text] [Related]
15. Arterial wall properties in patients with renal failure. Konings CJ; Dammers R; Rensma PL; Kooman JP; Hoeks AP; Kornet L; Gladziwa U; van der Sande FM; Leunissen KM Am J Kidney Dis; 2002 Jun; 39(6):1206-12. PubMed ID: 12046032 [TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL. Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894 [TBL] [Abstract][Full Text] [Related]
17. In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1. Paulsson JM; Held C; Jacobson SH; Lundahl J Scand J Immunol; 2009 Oct; 70(4):368-76. PubMed ID: 19751271 [TBL] [Abstract][Full Text] [Related]
18. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733 [TBL] [Abstract][Full Text] [Related]
19. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]